Condition
Sjogren's Disease clinical trials and research
Research outlook What's coming for Sjögren's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Sjogren's Disease clinical trials that are recruiting, at sites in 14 countries (most in United States (2), China (1), Turkey (Türkiye) (1)). By phase: Phase 1 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 14Countries
Newest Sjogren's Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ATG-201 in adults with autoimmune diseases | Phase 1 | Bengbu, Anhui and 21 other locations | Recruiting | Jul 28, 2026 |
| Predictors of fatigue over three months in people with Sjögren's disease | — | Kahramanmaraş | Recruiting | Apr 22, 2026 |
| OM336 in seropositive autoimmune diseases | Phase 1 | Hamilton, Waikato Region | Recruiting | Nov 14, 2025 |
| AlloNK® therapy combined with rituximab for treating certain autoimmune diseases | Phase 2 | Tuscaloosa, Alabama and 51 other locations | Recruiting | May 25, 2025 |
| Injecting bone marrow cells to treat dry mouth | Phase 1 | Madison, Wisconsin | Recruiting | Apr 30, 2024 |
All recruiting trials (5)
-
ATG-201 in adults with autoimmune diseases
This early, open-label study tests ATG-201 in adults with autoimmune diseases to see if it is safe and tolerable, and to get initial clues about how the body handles the drug and its effects.
-
Predictors of fatigue over three months in people with Sjögren's disease
This project will try to see if measures taken at baseline—like pain sensitivity, mood, sleep, and activity—predict how fatigue changes over three months in adults with Sjögren's disease who attend a rheumatology clinic.
-
OM336 in seropositive autoimmune diseases
A first-in-human study testing OM336 to see if it is safe and tolerable in adults with seropositive autoimmune diseases, given as subcutaneous injections in increasing doses.
-
AlloNK® therapy combined with rituximab for treating certain autoimmune diseases
This study is testing if a new treatment called AlloNK® combined with rituximab can help people with tough-to-treat autoimmune diseases feel better.
-
Injecting bone marrow cells to treat dry mouth
This study is testing if injecting special cells from bone marrow into the salivary glands can help people with dry mouth caused by conditions like Sjögren's disease feel better.
Related topics
Quick answers
How many Sjogren's Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (2 trials), China (1 trial), Turkey (Türkiye) (1 trial), Brazil (1 trial), Bulgaria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.